Listen Now

Topics Covered

  • Overview of Triple Negative Breast Cancer, in the Context of COVID-19
  • New Research on TNBC Presented at the San Antonio Breast Cancer Symposium (SABCS)
  • Triple Negative Breast Cancer-Specific Treatment Updates
  • The Important Role of Surgery in the Treatment of TNBC
  • Updates on Clinical Trials in Advancing Treatment Choices
  • The Increasing Role of Diagnostic Testing in Informing Treatment Options
  • Investigational New Therapies in Clinical Trials
  • New Developments in the Management of Treatment Side Effects
  • Communicating with the Health Care Team with Telehealth/Telemedicine Appointments
  • Roadmap to Prepare for These Appointments
  • Key Questions to Ask Your Health Care Team
  • Questions for Our Panel of Experts

Our Panel of Experts

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Lisa A. Newman, MD, MPH, FACS, FASCO, FSSO

Chief, Division of Breast Surgery, Director, Interdisciplinary Breast Program, Weill Cornell Medicine/NewYork-Presbyterian Hospital Network

Shaveta Vinayak, MD, MS

Assistant Professor, Division of Oncology, University of Washington, Assistant Member, Fred Hutchinson Cancer Research Center, Physician, Seattle Cancer Care Alliance

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation

Lauren Chatalian, MSW

Women & Children’s Program Manager, CancerCare

Brochure

You can download the brochure for this workshop (pdf)

Workshop Date

This workshop was originally recorded on December 15, 2020.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.